| Type | Title | Author(s) | Year | Views |
| Prognostic marker microRNA-125b inhibits tumorigenic properties of hepatocellular carcinoma cells via suppressing tumorigenic molecule eIF5A2Journal:Digestive Diseases and Sciences | TSANG, FH; Au, CHV; LU, W; SHEK, HP; LIU, ML; Luk, JMC; Fan, ST; Poon, RTP; Lee, NPY | 2014 | 56 |
| |
| Dysregulated expression of dickkopfs for potential detection of hepatocellular carcinomaJournal:Expert Review of Molecular Diagnostics | FATIMA, S; Luk, JMC; Poon, RTP; Lee, NPY | 2014 | 56 |
| |
| miR-122 targets pyruvate kinase M2 and affects metabolism of hepatocellular carcinomaPublisher:Public Library of Science. The Journal's web site is located at http://www.plosone.org/home.action | Liu, ML; Xu, Z; Shek, HP; Wong, KF; Lee, NPY; Poon, RTP; Chen, J; Luk, JMC | 2014 | 69 |
| |
| Circulating markers for prognosis of hepatocellular carcinomaJournal:Expert Opinion on Medical Diagnostics | Wong, KF; Xu, Z; Chen, J; Lee, NPY; Luk, JMC | 2013 | 90 |
| |
| Gene Expression Profiling Identified High-mobility Group AT-hook (HMGA2) as Being Frequently Upregulated in Esophageal Squamous Cell CarcinomaJournal:British Journal of Medicine and Medical Research Publisher:Sciencedomain International. The Journal's web site is located at http://www.sciencedomain.org/journal-home.php?id=12 | Cheung, LCM; Lai, KKY; Lam, AKY; Tang, JCO; Luk, JM; Lee, NP; Chung, Y; Tong, DKH; Law, S | 2013 | 252 |
| |
| New advances on disease biomarkers and molecular targets in biomedicine | Lee, NPY; Cheung, CY; Luk, JMC | 2013 | 56 |
| |
| Chimeric HBV/CCNE1 gene in hepatocellular carcinomaProceedings/Conference:APASL Liver Week 2013 Publisher:The Asian Pacific Association for the Study of the Liver (APASL). | Lee, NP; Chan, KT; Tan, W; Chan, JYK; Choi, MY; Lam, DHY; Tung, LN; Luk, JM | 2013 | 82 |
| |
| Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinomaPublisher:Cold Spring Harbor Laboratory Press, Publications Department. The Journal's web site is located at http://www.genome.org | Kan, Z; Zheng, H; Liu, X; Lee, NPY; Sung, WK; Poon, RTP; Fan, ST; Luk, JMC | 2013 | 123 |
| |
| Anti-cadherin-17 antibody modulates Beta-catenin signaling and tumorigenicity of hepatocellular carcinoma | Wang, Y; SHEK, HP; Wong, KF; Liu, LX; Zhang, XQ; Yuan, Y; Khin, E; Hu, MY; Wang, JH; Poon, RTP; Hong, W; Lee, NPY; Luk, JMC | 2013 | 136 |
| |
| Oncofetal gene SALL4 in aggressive hepatocellular carcinomaJournal:New England Journal of Medicine Publisher:Massachusetts Medical Society. The Journal's web site is located at http://content.nejm.org/ | Yong, KJ; Gao, C; Lim, JS; Poon, RTP; Fan, ST; Luk, JMC | 2013 | 85 |
| |
| Discovery of lamin B1 and vimentin as circulating biomarkers for early hepatocellular carcinomaJournal:Methods in Molecular Biology | Wong, KF; Luk, JMC | 2012 | 61 |
| |
| Mortalin-p53 interaction as a target for liver cancer therapyBook:Mortalin Biology: Life, Stress and Death | Lu, WJ; Lee, NPY; Wadhwa, R; Luk, JMC | 2012 | 124 |
| |
| Monoclonal antibody against cadherin-17 as a potential treatment for liver cancer (Poster & Abstract)Proceedings/Conference:The 47th Annual Meeting of the European Association for the Study of the Liver and the International Liver Congress 2012, Barcelona, Spain, 18-22 April 2012 | Lee, NPY; Wang, Y; Luk, JMC | 2012 | 83 |
| |
| Interleukin 23 promotes hepatocellular carcinoma metastasis via NF-kappa B induced matrix metalloproteinase 9 expressionPublisher:Public Library of Science. The Journal's web site is located at http://www.plosone.org/home.action | LI, J; Lau, G; Chen, L; Yuan, YF; Huang, J; Luk, JMC; Xie, D; Guan, X | 2012 | 83 |
| |
| Osteopontin as potential biomarker and therapeutic target in gastric and liver cancersJournal:World Journal of Gastroenterology Publisher:Beijing Baishideng BioMed Scientific Co., Ltd. The Journal's web site is located at http://www.wjgnet.com/1007-9327/index.htm | Cao, DX; Li, ZJ; Jiang, XO; Lum, YL; Khin, E; Lee, NPY; Wu, GH; Luk, JMC | 2012 | 131 |
| |
| A morpho-molecular prognostic model for hepatocellular carcinomaJournal:British Journal of Cancer Publisher:Nature Publishing Group. The Journal's web site is located at http://www.nature.com/bjc | Srivastava, S; Wong, KF; Ong, CW; Huak, CY; Yeoh, KG; Teh, M; Luk, JM; SaltoTellez, M | 2012 | 189 |
| |
| Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: A retrospective cohort study | Liu, AM; Yao, TJ; Wang, W; Wong, KF; Lee, NP; Fan, ST; Poon, RTP; Gao, C; Luk, JM | 2012 | 397 |
| |
| Tripterygium wilfordii bioactive compounds as anticancer and anti-inflammatory agentsJournal:Clinical and Experimental Pharmacology and Physiology Publisher:Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwellpublishing.com/journals/CEP | Wong, KF; Yuan, Y; Luk, JM | 2012 | 253 |
| |
| Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinomaPublisher:Nature Publishing Group. The Journal's web site is located at http://www.nature.com/onc | Fatima, S; Lee, NP; Tsang, FH; Kolligs, FT; Ng, IOL; Poon, RTP; Fan, ST; Luk, JM | 2012 | 330 |
| |
| An update on targeting Hippo-YAP signaling in liver cancerJournal:Expert Opinion on Therapeutic Targets Publisher:Informa Healthcare. The Journal's web site is located at http://www.expertopin.com/loi/ett | Liu, AM; Xu, Z; Luk, JM | 2012 | 293 |
| |
